Introduction
The continuous cell lines were taken from the stock of the cell Regulation of blood cell production, differentiation, and cerbank of the DSMZ (German Collection of Microorganisms and tain functional responses is mediated in part by specific hemaCell Cultures) 4 ,5 or were generously provided by the investitopoietic growth factors (or cytokines). The initial event in gators who established the cell lines for research purposes growth factor action consists of the factor's binding to its cog-( H-thymidine incorporation was determined by standard ␤ scintillation counting; stimulation indices (SI) refer to the untreated control culture; an SI Ͼ2 is considered to be significant. d The cytokines were used at the following concentrations: GM-CSF (5 ng/ml); SCF (50 ng/ml); TPO (20 ng/ml); 5637 CM (10% vol).
(Dr EA McCulloch, Toronto, Canada);
11 OCI-AML-5 (DSM 10 cell lines were washed, divided into two aliquots (starting concentration of 0.5 × 10 6 cells/ml in 1 ml) and incubated in ACC 247);
11 TF-1 (DSM ACC 334); 12 UT-7 (Dr M Souyri, Paris, France). 13 They were grown at 37°C in a humidified atmosmedium containing one of the following cytokines or CM: 5637 CM (at 10% vol); GM-CSF (at 5 ng/ml; kindly provided phere of air containing 5% CO 2 . The basal growth media (RPMI 1640 or alpha-MEM; Gibco BRL, Eggenstein, Germany)
by Dr A Mire-Sluis, London, UK); SCF (at 50 ng/ml; kindly provided by Dr A Mire-Sluis); or TPO (at 20 ng/ml; kindly prowere supplemented with 5-20% heat-inactivated (at 56°C for 45 min) fetal bovine serum (FBS) (Sigma, Deisenhofen, vided by Amgen, Thousand Oaks, CA, USA). The optimal concentration of each cytokine was determined empirically by the Germany). For selective experiments, cells were incubated in serum-free medium (Macrophage-SFM Medium; Gibco BRL). 3 H-thymidine uptake as outlined below. During the first week, the cells were weaned off the initially added cytokine by proFreedom of mycoplasma contamination was determined after thawing the cell lines by cultivation on agar and by frequent gressively decreasing the concentrations of this reagent while simultaneously adding and increasing daily the new cytokine. DAPI staining. 15 Cultures were passaged according to standard procedures: spent culture medium of suspension cell lines was exchanged at regular intervals (usually after 24-48 h); confluent adherent monolayers of cell line 5637 (DSM Immunofluorescence analysis of antigen cell surface expression ACC 35) were detached and split using trypsin-EDTA (Gibco BRL). 5 The growth factor-dependent cell lines were cultured routinely with recombinant cytokines or with supernatant (10-Surface protein expression of the following four cytokine receptors (R) was analyzed by flow cytometry applying 20% v/v) from the bladder carcinoma cell line 5637 producing several cytokines including granulocyte colony-stimulatspecific monoclonal antibodies (McAbs): anti-GM-CSFR␣ (CDw116; a mouse IgG1McAb; from Immunotech, Hamburg, ing factor CSF (G-CSF), granulocyte-macrophage CSF (GM-CSF), macrophage-CSF (M-CSF) and stem cell factor (SCF), but Germany); anti-Kit (CD117; a mouse IgG1 McAb; from Immunotech); anti-IL-3R␣ (CD123; a mouse IgG1 McAb; from not interleukin-3 (Il-3). 16 All cell lines were examined daily in their culture vessels under an inverted microscope. Cells were R&D Systems, Wiesbaden, Germany); and anti-MPL (a mouse IgG1 McAb; from Genzyme, Rü sselsheim, Germany). 17 Sevharvested in their logarithmic growth phase with viabilities exceeding 90% as determined by trypan blue dye exclusion; eral cell lineage-associated differentiation surface markers were examined with the following McAbs: anti-gpIIb (CD41; the cells were processed immediately or stored as pellets at −20°C or −80°C. The morphology of the cells was evaluated a mouse IgG1 McAb; from Immunotech); anti-gpIb (CD42b; a mouse IgG1 McAb; from Immunotech); anti-gpIIIa (CD61; in May-Grü nwald-Giemsa-stained cytospins prepared in a Shandon Cytospin 2 (Shandon, Frankfurt, Germany). The cell a mouse IgG1 McAb; from Dako, Hamburg, Germany); antiglycophorin A (VIE-G4; a mouse IgM McAb; kindly provided counts and viabilities were examined in standard hematocytometers.
by Prof W Knapp, Vienna, Austria); anti-HLA-DR (RFDR-2; a mouse IgG1 McAb; kindly provided by Prof G Janossy, London, UK). Non-reactive isotype-specific reagents were applied as controls. Binding of McAbs was assessed by the indirect
Establishment of TPO dependent cell lines
immunofluorescence technique using fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin heavy The original cultures of these 10 cell lines (Table 1) had all been maintained in 10-20% vol 5637 conditioned medium chain-specific antisera (Dunn, Asbach, Germany). Distribution of antigens was analyzed by flow cytometry (FACScan; (CM), the main cytokine ingredients of which are G-CSF (40 ng/ml) and GM-CSF (2 ng/ml). 16 The original cells of the Becton Dickinson, Heidelberg, Germany). Addition of propid-
Figure 1
Long-term culture of growth factor-dependent cell lines with GM-CSF, SCF, 5637 CM or TPO. Aliquots of the megakaryocyticmyeloid-monocytic leukemia cell lines MB-02, UT-7, MUTZ-2, MUTZ-3, OCI-AML-1 and OCI-AML-5 were cultured under identical conditions in the presence of either 10% (v/v) 5637 CM (containing mainly GM-CSF, G-CSF and SCF), 5 ng/ml GM-CSF, 50 ng/ml SCF or in the presence of 20 ng/ml TPO (starting concentration of 0.5 × 10 6 cells/ml in 1 ml). Prior to the start of this culture, cells now grown with TPO had been slowly weaned of the original cytokine (GM-CSF, SCF or 5637 CM) during the simultaneous, slowly increasing addition of TPO over 1-2 weeks. Viable cell numbers were determined at the indicated time-points in a hematocytometer. At the days indicated, the cultures were split 1:4, spent culture supernatants were exchanged at regular intervals without loss of any cells in order to expand maximally the cell populations. Note the lack of cell growth for the TPO-exposed cultures except for OCI-AML-1 where there was a steady increase in cell numbers in the TPO-culture starting at about day 21.
Figure 2
Establishment of TPO-dependent cell lines. Cultures were set up as described in Figure 1 . While growth of the GM-CSF-and TPOtreated cultures of HU-3, M-07e, and M-MOK was similar or identical, proliferation of the TF-1/TPO cell line started only very slowly at about day 15-17.
Table 2
Surface expression of cytokine receptors and differentiation markers on the GM-CSF-and TPO-dependent cell lines H-thymidine incorporation assays were performed at least The proliferative response of the cell lines to the various effectors was examined by standard 3 H-thymidine incorporation twice on different occasions. The following commercially sup-
Figure 3
Dependency of cell lines on GM-CSF or TPO for survival and proliferation. At days 97-118, aliquots of the four GM-CSF-or TPOdependent cell lines were incubated with either 5 ng/ml GM-CSF, 20 ng/ml TPO or medium only according to their previous treatment (GM-CSF-variants received GM-CSF and TPO-variants received TPO) or switched after thorough washings (but without any progressive adaptation period) to TPO or GM-CSF, respectively. Both GM-CSF-and TPO-variants died quickly in the absence of any growth factor. TPO-variants switched to GM-CSF showed vigorous and immediate growth. GM-CSF-variants switched to TPO grew poorly during this first week of exposure to TPO. Similar results were obtained at earlier passages of these cell lines (at days 36-46).
Figure 4
Flow cytometric analysis of surface proteins. Cultures of M-MOK cells were grown continuously with GM-CSF or TPO and were analyzed for MPL, CD41, CD42 and CD61 expression on day 87. Open curves, GM-CSF-treated cells; solid curves, TPO-treated cells. Isotypespecific irrelevant antibodies were used as negative controls (not shown). Note the up-regulation of the expression of all four proteins on the TPO-exposed cells in comparison with the GM-CSF-treated cells. plied recombinant cytokines were used (in parentheses are the electrophoresis using the Protean II chamber (BioRad, München, Germany) and were blotted onto nitrocellulose concentrations at which they were applied and the specific activities of the reagents): erythropoietin (EPO; 5 U/ml; membranes (Trans-Blot Transfer Medium; BioRad) by electroblotting (Sartoblot II-S; Sartorius, Gö ttingen, Germany). For Ͼ70 000 U/mg); G-CSF (100 U/ml = 10 ng/ml; Ͼ1.0 × 10 7 U/mg); GM-CSF (100 U/ml = 10 ng/ml; Ͼ1.0 × 10 7 U/mg); IL-STAT 3 and STAT 5 detection, the membranes were labelled with the respective murine McAbs (Dianova, Hamburg, 3 (100 U/ml = 10 ng/ml; Ͼ1.0 × 10 7 U/mg); SCF (50 ng/ml; 0.5-1.0 × 10 6 U/mg) (Boehringer Mannheim, Germany; R&D Germany) and specific bands were visualized applying a biotin/horseradish peroxidase system (Amersham) in combiSystems). Recombinant human TPO (used at 100 U/ml) was kindly provided by Zymogenetics (Dr DC Foster, Seattle, WA, nation with the Renaissance Western Blot Chemoluminescence Reagent protocol (Du Pont NEN, Bad Homburg, USA).
18 Recombinant PIXY-321 (a GM-CSF/IL-3 fusion protein; used at 10 ng/ml) was kindly provided by Immunex Germany). (Seattle, WA, USA). As the cell lines were constitutively dependent on externally added growth factors and normally grown in medium containing such factors, the cells were Results washed extensively prior to the experiments.
Establishment of TPO-dependent cell lines
In order to establish TPO-dependent sublines, we cultured Western blot analysis cells from 10 constitutively growth factor-dependent leukemia cell lines (Table 1) in the presence of 20 ng/ml TPO and the For Western blot analysis, 2 × 10 6 cells were pelleted, resuspended in 25 l protease inhibitor buffer containing 0.1 M respective control cultures in GM-CSF, SCF or 5637 CM for more than 5 weeks (Figures 1 and 2) . In previous studies, 1, 3 NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1 g/ml aprotinin and 100 g/ml phenylmethylsulfonyl fluoride, and lysed we found that the cell lines HU-3, M-07e, M-MOK, MUTZ-3, OCI-AML-1 and TF-1 responded proliferatively in a shortby boiling in 25 l SDS-PAGE (polyacrylamide gel) sample buffer containing 15% glycerol, 125 mM Tris-HCl (pH 6.8),
term (48 h) thymidine uptake assay to incubation with TPO (a response with a stimulation index Ͼ2 was considered 5 mM EDTA, 2% SDS, 0.1% bromphenol blue and 1% ␤-mercaptoethanol. Proteins were separated in a 9% SDS-PAGE by significant) ( Table 1) . Of the remaining four cell lines, two cul- tures, MB-02 and UT-7, were chosen for this study because lines were kept in continuous culture for more than 6 months they are of megakaryocytic origin and display markers of this without loss of their dependency on TPO. We confirmed the cell lineage; the myeloid cell lines MUTZ-2 and OCI-AML-5 dependency of these newly established cell lines on TPO for were used as controls. MB-02, MUTZ-2, MUTZ-3, OCI-AMLcell survival and growth and thus excluded the outgrowth of 5 and UT-7 clearly did not grow in the continuous presence a cytokine-independent subclone: in the presence of the of TPO while vigorously growing in the presence of GM-CSF, respective cytokine (GM-CSF or TPO), the HU-3, M-07e, M-SCF or 5637 CM (Figure 1 ). The three cell lines HU-3, M-07e MOK and TF-1 cells proliferated normally, but stopped proand M-MOK grew with TPO as well as they did with GM-CSF liferation and eventually died when the cytokines were omitor 5637 CM whereas OCI-AML-1 and TF-1 showed a someted from the culture medium (Figure 3) . When the cells of the what delayed, but still significant proliferation upon exposure four TPO-dependent variants were switched back to GM-CSF to TPO (Figures 1 and 2 ). These long-term cultures were exposure (without an adaption period), the cells grew immedinamed in accordance with the respective cytokine, for ately well or even better than with TPO in all four instances; instance, HU-3/GM vs HU-3/TPO (Table 2 ). In the case of in contrast, cultures continuously incubated with GM-CSF and OCI-AML-1, it appeared that a cytokine-independent subswitched to TPO (in the absence of GM-CSF), did not show clone had grown out as cytokine-deprived OCI-AML-1/TPO immediately vigorous growth (Figure 3) . We determined the cells grew as well as their sister cells incubated with either doubling times of the cell lines by incubating them with GM-CSF or TPO. Thus, all further experiments were perfor-10 ng/ml GM-CSF or 10 ng/ml TPO: the TPO-variants showed med with the GM-CSF-and TPO-dependent variants of HUsomewhat longer doubling times (Table 2) . 3, M-07e, M-MOK and TF-1. These four TPO-dependent cell while expression of the erythroid marker glycophorin A was decreased in 2/4 cell lines. M-MOK/TPO and TF-1/TPO cells were significantly larger than their GM-CSF-counterparts in the forward scatter analysis; while the GM-CSF-and TPO-variants of M-07e were of similar size, only the HU-3/GM cells were larger than their TPO-treated sister cells.
Morphological analysis
Both the GM-CSF-and the TPO-exposed variants of the cell lines HU-3 and M-MOK grew as single cells in suspension with only few cells forming small aggregates. Compared with their GM-CSF-treated sister cultures, significantly higher percentages of the M-07e/TPO and TF-1/TPO cells adhered to the plastic bottom of the plates with long cellular extensions. Of note also are the giant, polynucleated cells that were seen in the TF-1/TPO cultures accounting for about 1-3% of the population; none of the other cultures, neither the GM-CSFnor the TPO-treated lines, displayed significant numbers of these giant cells. With regard to the morphological appearance of the May-Grü nwald-Giemsa-stained mononucleated cells, there were no significant differences between the respective pairs of GM-CSF-and TPO-incubated cells. The GM-CSF-and the TPO-treated cells displayed very similar or identical morphological features: the surface of the cells was highly deformed with cytoplasmic extrusions, reminiscent of the physiological release of platelets from the periphery of the cell ('membrane blebbing') ( Figure 5 ).
Expression of STAT 3 and STAT 5 molecules
The long-term cultivation of the four cell lines with either GM-CSF or TPO did not alter the pattern of STAT 3 and STAT 5 expression ( Figure 6 ). All variants showed constitutively strong expression of both proteins.
TPO as survival factor Mitogenic effects of several cytokines Surface expression of cytokine receptors and differentiation markers
As shown in Table 3 , the TPO-treated variants responded proliferatively to the same cytokines as their parental GM-CSFUsing flow cytometry, we examined the GM-CSF-and TPOtreated cell lines for differences in the expression of several treated cells. Apart from TPO, 5637 CM, EPO (only on HU-3 and TF-1), GM-CSF, IL-3, PIXY-321 and SCF had mitogenic cytokine receptors and surface proteins associated with erythroid and megakaryocytic differentiation ( Table 2, effects on these cell lines; G-CSF did not stimulate growth in any of these cultures. The TPO-exposed variants of HU-3, M- Figure 4 ). We considered a (reproducible) 5% difference in antigen expression to be significant. In comparison with the 07e and TF-1 showed higher 3 H-thymidine incorporations relative to the respective untreated control cells than the sister GM-CSF-dependent variants, the GM-CSFR and IL-3R were down-regulated in 4/4 and in 3/4 TPO-dependent cell lines, cultures grown in GM-CSF. The reverse, a stronger proliferative response of the GM-CSF-variant to incubation with 5637 respectively; c-kit and MPL were up-regulated in 2/4 and 4/4 cell lines, respectively; levels of the megakaryocytic markers CM, GM-CSF, IL-3, PIXY-321 and SCF was seen for M-MOK. Dose-response curves demonstrated a significantly stronger CD41/CD42 and CD61 were increased in 3/4 (percentages of positive cells) and 2/4 cell lines (intensity of expression proliferative stimulus of TPO on the TPO-cell lines than on the GM-CSF-cell lines (Figure 8 ). according to the mean fluorescence channel), respectively,
Figure 8
Dose-response curves to TPO of the GM-CSF-and TPO-dependent variants. Cells were incubated in 96-well plates with decreasing concentrations of TPO for 48 h. Proliferation was measured by the 3 H-thymidine assay. Results are expressed as percentages of thymidine incorporation in comparison with the respective untreated control cells. Note the significantly stronger cell proliferation induced by TPO in the TPO-variants than in the GM-CSF-variants.
Discussion
models for gaining insights into the molecular genetic regulation of differentiation and proliferation events has become evident in the plethora of studies employing leukemia cell Studies on hematopoietic stem cells, precursor cells and their immature progeny are usually hampered by the paucity of lines. 4, 19 Thus, in this study TPO was used to establish TPO-dependent these cell elements in the normal hematopoietic tissues and the necessity for extensive purification procedures. Therefore, continuous human leukemia-derived cell lines. The four lines (HU-3/TPO, M-07e/TPO, M-MOK/TPO and TF-1/TPO) derived such studies often take recourse to continuous hematopoietic cell lines established from patients with leukemia which from constitutively growth factor-dependent cell lines were continuously grown for more than 6 months in TPO-supported recapitulate many of the developmental steps of normal cells. While there are certainly disadvantages of the work with cell liquid culture. The cells are TPO-dependent rather than merely TPO-responsive as omission of TPO in the cell culture comlines and not every result should be uncritically extrapolated to the normal situation, leukemia-derived cell lines also pospletely abrogated cell proliferation. While the swift change from incubation with GM-CSF to TPO was not successful, rather sess on the other hand some indisputable advantages, not the least being their unlimited availability, monoclonality, and requiring a certain adaptation period, all TPO-treated cell lines could be easily switched back to GM-CSF. ready accessability. Thus, these cultures are amenable to various in vitro manipulations. Again, without ignoring the limiUnder serum-free conditions TPO promoted cell viability by repressing apoptosis in the TPO-dependent cultures. Thus, tations of these in vitro models (it might be argued that any in vitro scenario is artificial), cell lines have certainly provided depending on the experimental setting (without or with FBScontaining culture medium -there are probably co-stimulatory unique and important models to perform any kind of studies on hematopoietic cells. 19 factors in the FBS), TPO can act as a survival factor or as a proliferation-inducing agent. 20 The survival signal provided by TPO has a tremendous clinical potential and there is an explosion of research activities in this field. However, it is TPO is, however, not specific as GM-CSF also rescued TPOtreated cells from apoptosis upon withdrawal of TPO. often difficult to evaluate the significance of these observations in vivo because of the scarcity of the cells of interest.
While GM-CSF and IL-3 receptors were down-regulated in the TPO-treated cells, c-kit (SCF receptor) and MPL (TPO Therefore, we felt it was important to generate a stable, reproducible, accessible and significant in vitro system that is sufreceptor) were up-regulated. The cytokines EPO, GM-CSF, IL-3, PIXY-321, SCF and TPO had stronger growth-stimulating ficiently representative to perform the extensive examinations of the biological functions of TPO. The utility of such cell line effects on three or all four of the TPO-dependent cell lines
